Monday, November 2, 2020

Medication Guide - 11/2/2020

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Silenor Doxepin Hydrochloride TABLET;ORAL 022036 CURRAX 10/29/2020
Trulance Plecanatide TABLET;ORAL 208745 SALIX 10/29/2020
Symbyax Fluoxetine Hydrochloride; Olanzapine CAPSULE;ORAL 021520 LILLY 10/23/2020
Tymlos Abaloparatide SOLUTION;SUBCUTANEOUS 208743 RADIUS HEALTH INC 10/23/2020
Tymlos Abaloparatide SOLUTION;SUBCUTANEOUS 208743 RADIUS HEALTH INC 10/23/2020
Campath Alemtuzumab VIAL; INTRAVENOUS 103948 GENZYME 10/22/2020
Epidiolex Cannabidiol SOLUTION;ORAL 210365 GW RES LTD 10/22/2020
Lemtrada Alemtuzumab INJECTABLE;INJECTION 103948 GENZYME 10/22/2020

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment